Diabetes and Endocrinology
Home Diabetes and Endocrinology
Meta-Analysis Links Omega-3 Fatty Acid Consumption to T2DM
Composition, ethnicity, trial duration, recruited age all influence effect of omega-3 on T2DM progression
Sequential Empagliflozin, Linagliptin Diabetes Tx Effective
Glucose control most probably mediated by effects on alpha- and beta-cell function
Fenofibrate May Reduce CVD in Patients With DM, Dyslipidemia
No reduction in primary outcome for 4,644 ACCORD participants followed for median of 9.7 years
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Reduced all-cause death for chronic kidney disease, congestive heart failure, chronic liver disease
DASH Tops the 2017 Rankings for Best Diets
U.S. News & World Report ranks Mediterranean diet as second, up from fourth place
ACP Updates Recommendations for Oral Medications in T2DM
Recs serve as update to 2012 American College of Physicians guideline
Sex Hormone-Sensitive Gene Complex Implicated in PMDD
Study adds to evidence of a biological cause of condition, researchers say
December 2016 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2016. This roundup includes...
Lactobacillus Supplement Doesn’t Impact HbA1c in Type 2 Diabetes
Patients receiving highest dose of L. reuteri have increases in insulin sensitivity index versus baseline
Low Vitamin D Linked to Incident Frailty in Older Women
Correlation is attenuated after accounting for cardiometabolic diseases
